Advanced search
Publication Cover
International Journal of Hyperthermia Volume 38, 2021 - Issue 1
Submit an article Journal homepage
1,992
Views
9
CrossRef citations to date
0
Altmetric
Articles

Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy

Laure Doisya Department of Surgical Oncology 2, Institut Paoli Calmettes Cancer Center, Marseille, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7783-0211
ORCID Icon,
Arnaud Cimierb Department of Urology, Jean Monnet University, Nord Academic Hospital, Saint-Etienne, France
,
Aurélien Adypagavanec Department of Urology, Kremlin-Bicêtre Academic Hospital, Bicêtre, France
,
Jochen Walza Department of Surgical Oncology 2, Institut Paoli Calmettes Cancer Center, Marseille, France
,
Thibault Marquettea Department of Surgical Oncology 2, Institut Paoli Calmettes Cancer Center, Marseille, France
,
Thomas Maubona Department of Surgical Oncology 2, Institut Paoli Calmettes Cancer Center, Marseille, France
,
Stanislas Rybikowskia Department of Surgical Oncology 2, Institut Paoli Calmettes Cancer Center, Marseille, France
,
Sami Fakhfakha Department of Surgical Oncology 2, Institut Paoli Calmettes Cancer Center, Marseille, France
,
Kevin Loverdea Department of Surgical Oncology 2, Institut Paoli Calmettes Cancer Center, Marseille, France
,
Nicolas Mottetb Department of Urology, Jean Monnet University, Nord Academic Hospital, Saint-Etienne, France
,
Jacques Iranic Department of Urology, Kremlin-Bicêtre Academic Hospital, Bicêtre, France
,
Eric Lechevallierd Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM, Conception Academic Hospital, Marseille, France
,
Dominique Rossie Department of Urology, Aix-Marseille University, APHM, Nord Academic Hospital, Marseille, France
,
Gwenaelle Gravisf Department of Medical Oncology, Institut Paoli Calmettes Cancer Center, Marseille, France
&
Géraldine Pignota Department of Surgical Oncology 2, Institut Paoli Calmettes Cancer Center, Marseille, France
 show all
Pages 1633-1638 | Received 22 Mar 2021, Accepted 28 Oct 2021, Published online: 14 Nov 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kristin Grabe-Heyne, Christof Henne, Isaac Odeyemi, Johannes Pöhlmann, Waqas Ahmed & Richard F. Pollock. (2023) Evaluating the cost-utility of intravesical Bacillus Calmette-Guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK. Journal of Medical Economics 26:1, pages 411-421.
Read now

Articles from other publishers (8)

Yingying Yang, Hongquan Liu, Yongli Chu, Jipeng Wang, Jian Ma, Guixin Ding, Xingjun Bao, Yuanshan Cui & Jitao Wu. (2024) The Efficacy and Safety of Hyperthermic Intravesical Chemotherapy Compared with Other Instillation Methods in Treating Intermediate- and High-Risk Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. International Journal of Clinical Practice 2024, pages 1-13.
Crossref
M. Teresa Melgarejo Segura, Yaiza Yáñez Castillo, Macarena Lozano Lorca, Ana Morales Martínez, Miguel Ángel Arrabal Polo & Miguel Arrabal Martín. (2024) Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review. Urologic Oncology: Seminars and Original Investigations.
Crossref
Fatih Akbulut, Yasar Pazir, Abdullah Esmeray, Akif Erbin, Faruk Ozgor & Omer Sarilar. (2023) The efficacy of hyperthermic intravesical chemotherapy in high-risk non-muscle-invasive bladder cancer patients with BCG intolerance. Urologia Journal 90:4, pages 631-635.
Crossref
Yasar Pazir, Abdullah Esmeray, Ufuk Caglar, Akif Erbin, Faruk Ozgor, Omer Sarilar & Fatih Akbulut. (2023) Comparison of hyperthermic intravesical chemotherapy and Bacillus Calmette–Guerin therapy in high-risk non-muscle invasive bladder cancer: a matched-pair analysis. International Urology and Nephrology 56:3, pages 957-963.
Crossref
Samantha Conroy, Karl Pang, Ibrahim Jubber, Syed A. Hussain, Derek J. Rosario, Marcus G. Cumberbatch, James W. F. Catto & Aidan P. Noon. (2022) Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients. BJUI Compass 4:3, pages 314-321.
Crossref
A. Cimier, S. Thach, B. Lacroix & C. Mariat. (2023) Évaluation de l’efficacité et de la tolérance de la thermo-chimiothérapie intravésicale HIVEC pour les tumeurs de vessie non infiltrant la musculeuse de risque intermédiaire et de haut risque. Progrès en Urologie 33:5, pages 254-264.
Crossref
Vassili Anastay, Michael Baboudjian, Alexandra Masson-Lecomte, Cédric Lebacle, Alexandre Chamouni, Jacques Irani, Xavier Tillou, Thibaut Waeckel, Arnaud Monges, Céline Duperron, Gwenaelle Gravis, Jochen Walz, Eric Lechevallier & Géraldine Pignot. (2023) Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?. Cancers 15:5, pages 1455.
Crossref
Mihai Dorin Vartolomei, Matteo Ferro, Beat Roth, Jeremy Yuen-Chun Teoh, Paolo Gontero & Shahrokh F. Shariat. (2022) Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update. Current Opinion in Urology 32:5, pages 575-583.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.